Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to study the effects (good and bad) of bevacizumab
alone, bevacizumab with low-dose continuous chemotherapy (called metronomic chemotherapy), or
bevacizumab with capecitabine, on you and your cancer. The goals of the study will be to:
- Examine the safety of these drugs
- See how easy or difficult it is to be treated with them
- Monitor for any signs of recurrent cancer
- Look at blood markers that might indicate how the treatment is working
Phase:
N/A
Details
Lead Sponsor:
Harold J. Burstein, MD, PhD
Collaborators:
Beth Israel Deaconess Medical Center Genentech, Inc. Indiana University School of Medicine University of California, San Francisco University of North Carolina